View Older Stories View More Recent Stories

Nov 7, 2019 04:05PM Novavax Reports Third Quarter 2019 Financial Results
Nov 7, 2019 04:05PM Novavax Reports Third Quarter 2019 Financial Results
Oct 31, 2019 04:05PM Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 7, 2019
Oct 31, 2019 04:05PM Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 7, 2019
Oct 15, 2019 07:07AM Novavax (NVAX) Commences Pivotal Phase 3 Clinical Trial of NanoFlu Influenza Vaccine in Older Adults
Oct 15, 2019 07:00AM Novavax Initiates Pivotal Phase 3 Clinical Trial of NanoFlu Influenza Vaccine in Older Adults
Oct 15, 2019 07:00AM Novavax Initiates Pivotal Phase 3 Clinical Trial of NanoFlu Influenza Vaccine in Older Adults
Sep 19, 2019 07:00AM Novavax to Present at the Ladenburg Thalmann 2019 Healthcare Conference
Sep 19, 2019 07:00AM Novavax to Present at the Ladenburg Thalmann 2019 Healthcare Conference
Sep 6, 2019 07:00AM Novavax to Present at the H.C. Wainwright 21st Annual Global Investment Conference
Sep 6, 2019 07:00AM Novavax to Present at the H.C. Wainwright 21st Annual Global Investment Conference
Aug 12, 2019 07:06AM Novavax (NVAX) Highlights New Data from Novavax Phase 3 Prepare Trial of ResVax at 2019 IDSOG Meetings
Aug 12, 2019 07:00AM New Data from Novavax Phase 3 Prepare™ Trial of ResVax™ Presented at 2019 IDSOG Annual Meeting
Aug 12, 2019 07:00AM New Data from Novavax Phase 3 Prepare™ Trial of ResVax™ Presented at 2019 IDSOG Annual Meeting
Aug 8, 2019 07:00AM Novavax Scientific Leadership to Present New RSV Maternal Immunization Program Phase 3 Data and Participate in Discussion on RSV at the 2019 IDSOG Annual Meeting
Aug 8, 2019 07:00AM Novavax Scientific Leadership to Present New RSV Maternal Immunization Program Phase 3 Data and Participate in Discussion on RSV at the 2019 IDSOG Annual Meeting
Aug 7, 2019 04:05PM Novavax Reports Second Quarter 2019 Financial Results
Aug 7, 2019 04:05PM Novavax Reports Second Quarter 2019 Financial Results
Aug 7, 2019 04:05PM Novavax Reports Second Quarter 2019 Financial Results
Aug 5, 2019 04:10PM Novavax (NVAX) Reaches Agreement with the FDA on Pivotal Phase 3 Trial Design for NanoFlu
Aug 5, 2019 04:05PM Novavax Reaches Agreement with the FDA on Pivotal Phase 3 Trial Design for NanoFlu
Aug 5, 2019 04:05PM Novavax Reaches Agreement with the FDA on Pivotal Phase 3 Trial Design for NanoFlu
Aug 1, 2019 09:25AM Novavax to Host Conference Call to Discuss Second Quarter Financial Results on August 7, 2019
Aug 1, 2019 09:25AM Novavax to Host Conference Call to Discuss Second Quarter Financial Results on August 7, 2019
Jul 31, 2019 04:30PM Novavax and Catalent Announce Closing of Strategic Partnership
Jul 31, 2019 04:30PM Novavax and Catalent Announce Closing of Strategic Partnership
Jun 27, 2019 08:44AM Novavax (NVAX) and Catalent Biologics Enter Strategic Partnership
Jun 27, 2019 07:08AM Novavax (NVAX) Confirms Accelerated Approval Pathway Available for Licensure of NanoFlu
Jun 27, 2019 07:00AM Novavax Confirms Accelerated Approval Pathway Available for Licensure of NanoFlu™
Jun 27, 2019 07:00AM Novavax Confirms Accelerated Approval Pathway Available for Licensure of NanoFlu™
Jun 27, 2019 06:59AM Novavax and Catalent Biologics Enter Strategic Partnership: Allowing Catalent Biologics to Expand Gene Therapy Footprint with Acquisition of Novavax’ Manufacturing Assets and Capabilities
Jun 27, 2019 06:59AM Novavax and Catalent Biologics Enter Strategic Partnership: Allowing Catalent Biologics to Expand Gene Therapy Footprint with Acquisition of Novavax’ Manufacturing Assets and Capabilities
Jun 10, 2019 07:09AM Novavax (NVAX) Provides Updates on Global Pathways to Licensure for ResVax
Jun 10, 2019 06:59AM Novavax Provides Updates on the Global Pathways to Licensure for ResVax™
Jun 10, 2019 06:59AM Novavax Provides Updates on the Global Pathways to Licensure for ResVax™
Jun 4, 2019 04:05PM Novavax CFO John Trizzino to Discuss Future of Influenza Vaccines on Industry Panel at 2019 BIO International Convention
Jun 4, 2019 04:05PM Novavax CFO John Trizzino to Discuss Future of Influenza Vaccines on Industry Panel at 2019 BIO International Convention
May 10, 2019 04:05PM Novavax Announces Adjustment of Conversion Rate for its 3.75% Convertible Senior Notes due 2023
May 10, 2019 04:05PM Novavax Announces Adjustment of Conversion Rate for its 3.75% Convertible Senior Notes due 2023
May 8, 2019 04:05PM Novavax Announces Reverse Stock Split of Common Stock
May 8, 2019 04:05PM Novavax Announces Reverse Stock Split of Common Stock
May 2, 2019 04:05PM Novavax Reports First Quarter 2019 Financial Results
May 2, 2019 04:05PM Novavax Reports First Quarter 2019 Financial Results
May 1, 2019 04:05PM Novavax Announces Presentation of Phase 3 Data from RSV Maternal Immunization Program at 37th Annual Meeting of the European Society for Pediatric Infectious Diseases
May 1, 2019 04:05PM Novavax Announces Presentation of Phase 3 Data from RSV Maternal Immunization Program at 37th Annual Meeting of the European Society for Pediatric Infectious Diseases
Apr 25, 2019 04:05PM Novavax to Host Conference Call to Discuss First Quarter Financial Results on May 2, 2019
Apr 25, 2019 04:05PM Novavax to Host Conference Call to Discuss First Quarter Financial Results on May 2, 2019
Apr 9, 2019 04:19PM Novavax (NVAX) to Present RSV Maternal Immunization Program Phase 3 Data and Participate in Panel on COPD
Apr 9, 2019 04:05PM Novavax Scientific Leadership to Present RSV Maternal Immunization Program Phase 3 Data and Participate in Panel on COPD at World Vaccine Congress
Apr 9, 2019 04:05PM Novavax Scientific Leadership to Present RSV Maternal Immunization Program Phase 3 Data and Participate in Panel on COPD at World Vaccine Congress
View More Recent Stories View Older Stories